Tag: ulcerative colitis support
This Week in IBD: Your Weekly Roundup for December 8-14, 2025
Welcome to This Week’s Roundup Welcome back to our weekly digest of the latest IBD content! This week has been particularly rich with groundbreaking research…
Could These 4 Dietitian-Recommended Teas Bring Relief to Your Ulcerative Colitis Symptoms?
A Natural Approach to Managing UC Discomfort Living with ulcerative colitis means constantly searching for safe, effective ways to manage symptoms and support…
Finding My Voice: How Ulcerative Colitis Taught Me True Professional Confidence
This story represents a composite of common IBD experiences and is presented to help readers feel less alone in their journey. The Morning That Changed…
This Week in IBD: Your Weekly Roundup for November 23-29, 2025
Introduction Welcome to this week’s roundup from IBD Movement! We published 16 comprehensive articles covering the latest developments in IBD care, from…
The Choice That Changed Everything: My Journey to Peace with Colectomy
This story represents a composite of common IBD experiences and is presented to help readers feel less alone in their journey. The Moment Everything Shifted I…
Long-Term Hope: Vedolizumab Proves Safe for Extended IBD Treatment
New long-term safety data for Vedolizumab shows encouraging results for IBD patients, with low rates of serious side effects even after years of use. This evidence provides much-needed reassurance for those considering or currently using this targeted biologic therapy.
A Swallowable Pill Could Replace Colonoscopies for IBD Patients
Researchers are developing a swallowable ‘magnetic pill’ that could replace many colonoscopies with a simple, non-invasive procedure. For IBD patients who need frequent monitoring, this technology could be life-changing.
Finally, Clearer Answers: New Study Compares IBD Imaging Options
New research directly compares MRI and CT imaging for IBD, showing both are highly effective but excel in different areas. This evidence supports personalized imaging approaches that consider individual patient factors like age, symptoms, and long-term monitoring needs.
Asia-Pacific’s IBD Crisis: Why Early Action Could Change Everything
Asia-Pacific countries are developing new strategies to tackle rising IBD rates through early intervention and comprehensive care. This shift could transform outcomes for millions living with Crohn’s disease and ulcerative colitis in the region.
New Hope: STELARA Seeks FDA Approval for Kids with UC
Johnson & Johnson has submitted an FDA request for STELARA approval in pediatric ulcerative colitis patients. This could become the first biologic targeting dual inflammation pathways specifically for children with UC, offering new hope for families with limited treatment options.
